Cencora, Inc. (COR) Stock Price & Analysis
Market: NYSE • Sector: Healthcare • Industry: Medical - Distribution
Cencora, Inc. (COR) Profile & Business Summary
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Key Information
| Ticker | COR |
|---|---|
| Exchange | NYSE |
| Official Site | https://www.cencora.com |
Market Trend Overview for COR
One model, two time views: what the market looks like right now, and where the larger trend is heading over time.
SRE (WhaleQuant Structural Regime Engine) SRE evaluates how price structure evolves across daily and weekly timeframes to define the prevailing market regime. Beyond identifying trends, consolidations, and exhaustion phases, it distinguishes between raw structural strength and deployable participation quality. The model dynamically adjusts for structural context and extension risk, assessing whether conditions are supportive, stretched, fragile, or structurally impaired. Its purpose is not to forecast precise price levels, but to determine whether risk deployment is aligned with underlying market structure.
Longer-Term Market Trend (Mid to Long Term)
Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-08-28 (ET)
As of 2026-08-28, COR is starting to move higher. Over the longer term, the trend remains bearish.
COR last closed at 322.03. The price is about 0.8 ATR above its recent average price (314.44), and the market is currently in an early upward move. Price at 322.03 is holding above minor support near 302.01. If price continues higher, it may face light resistance around 322.50. View Support & Resistance from Options
Short-term strength is developing against a weaker long-term trend, which increases the risk of downside reversals.
Trend score: 55 out of 100. Overall alignment is unclear. The market is currently in an early-stage uptrend. The longer-term trend is still negative, but short-term signals are not yet confirming it.
A key downside risk boundary is near 295.78. If price falls below this area, the current structure would likely weaken further.
A systematic trend-activation signal was most recently triggered on 2026-07-02, reflecting a technical shift toward positive directional alignment.
[2026-08-24] Price moved quickly and looked strong, but participation was limited.
Recent bars show mixed price behavior without a clear shift in structural quality or efficiency.
There was no clear sign of meaningful positions being carried into the overnight session.
The model sees a credible bullish edge, with 65.7% upside probability, strong signal alignment, and reward/risk that remains meaningfully favorable.
Up probability is 65.7%, with predictability at 61% and signal agreement at 93%. Reversal risk is 12%, while reward/risk stands at 0.35. That suggests the directional case is supported by broad confirmation and still retains usable quality. At the same time, recent price behavior has shown failed reversal memory.
NOTE: This next-day up/down probability forecast module is still being tested for accuracy. Please do not rely on it for investment decisions. The model does not account for black swan events or company-specific fundamental news, and its estimates are based solely on technical conditions, capital flow, and market sentiment. View forecast history
This estimate uses 1-minute price, volume, and VWAP data from the last 27 trading days, with turnover-based decay. The sample period is 2026-07-23 to 2026-08-28. The current price is 322.03, 1.48% above the estimated average cost of 317.33. An estimated 76.6% of recent positioning is below the current price, while 22.9% is above it. The peak-density price is 312.50. The largest concentrated cost region is 316.55 to 320.15 and contains 20.9% of the estimated distribution. The current price is within the 320.95 to 322.95 cost region. The nearest region below the current price is 316.55 to 320.15. The nearest region above the current price is 323.15 to 323.45.
Short Interest & Covering Risk for COR
This analysis looks at overall short interest positioning, focusing on the broader setup rather than short-term noise.
Shows how likely a short squeeze may be under current market conditions.
Short Exposure Percentile
Short interest is relatively low, indicating limited pressure from short positions. (Historical percentile: 0%)
Structure Analysis
COR Short positioning looks normal. Current days to cover is 4.2 trading days, meaning short positions would unwind somewhat slower than average. Short covering is likely to have a normal impact on price moves. No meaningful structural fragility is currently detected (Fragility Score 24/100, DTC percentile 71%) and liquidity contracting meaningfully (volume -33%).
Risk Summary
No clear bull trap characteristics detected. Recent price behavior remains broadly consistent with current positioning.This reading helps confirm that current price action remains structurally healthy and does not indicate elevated trap risk.
Why Price Reactions May Be Stronger?
Average trading volume is weakening, indicating contracting liquidity. Price action is compressing (range is tightening), which can make breaks more sensitive. Adaptive thresholds applied to liquidity weakness, near-high detection, and compression sensitivity. As a result, similar news or market events could lead to price moves about 1× larger than usual.
Note:
Short interest data is reported every two weeks by
FINRA.
The most recent snapshot is
2026-07-31 (ET).
Because this data updates slowly, it is not intended to predict short-term price moves. Instead, it helps describe longer-term market structure and where pressure may be building if prices begin to move.